Rob Volansky is a staff writer for HEMONC TODAY, a publication associated with Healio. Rob covers a wide range of topics in the field of hematology and oncology, including the latest research, treatment advances, and clinical trials. His articles provide valuable insights and updates for healthcare professionals and researchers in the field.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Rob's coverage predominantly focuses on healthcare and pharmaceuticals, particularly in the field of rheumatology and autoimmune diseases. He relies heavily on data citations, indicating a preference for evidence-based information.
Since Rob covers a niche area within the medical field, he is likely to be interested in pitches that provide new research findings or expert insights related to rheumatology, autoimmune diseases, COVID-19 impact on these conditions, vaccines' effect on patients with such illnesses, and developments in relevant medications.
Given his high reliance on data citations, sources with access to cutting-edge research or clinical trial results would have significant appeal. Expert commentary from professionals directly involved in treating these conditions could also capture his interest.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Rob Volansky
SAN DIEGO — Although most osteoarthritis experts agree that diet and exercise are critical to disease management, detailed guidance on either remain lacking, according to a presenter at the 2024 Congress of Clinical Rheumatology West.“There is a long history of failed trials in osteoarthritis,” Amanda E. Nelson, MD, MSCR, RhMSUS, professor of medicine and adjunct associate
By: Rob Volansky, Shenaz Bagha
SAN DIEGO — Improving depressive symptoms can reduce patients' chronic pain, according to a presenter at the 2024 Congress of Clinical Rheumatology West.
By: Rob Volansky, Shenaz Bagha
A recent investigation into the molecular roots of systemic lupus erythematosus may point the way toward a new generation of therapeutic targets, according to the researchers.
By: Rob Volansky
SAN DIEGO — Vagus nerve stimulation may represent a “novel therapeutic option” for patients with rheumatoid arthritis, according to data presented at the 2024 Congress of Clinical Rheumatology West.
By: Rob Volansky, Shenaz Bagha
Healio's “Hooked on Rheum” series has traditionally featured providers who can look back on their career and identify the turning points that lead them to their current position.
By: Rob Volansky
The largest retailer in the nation has sampled a taste of the autoimmune specialty pharmacy market, and has decided it wants more.
By: Rob Volansky
Chromosomal, hormonal and structural differences between the bodies of girls and boys may explain why osteoarthritis incidence is elevated in women
By: Rob Volansky
Telemedicine access and use in rheumatology has fluctuated wildly over the last half decade, from near nonexistence through 2019 to its highwater mark during the emergency phase of the COVID-19 pandemic.
By: Rob Volansky, Shenaz Bagha
Systemic sclerosis is the most challenging diagnosis to make among rheumatic and autoimmune conditions, according to 91% of respondents in a market analysis from Spherix Global Insights.
From a young age, I was fascinated by the human body and its complexities. Growing up in a small village in southern Italy, I had an insatiable curiosity about science and how we experience pain, heal and recover.
(833) 317-6278 
